SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.

Closure of Register of Shareholders or Designation of Record Date

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

SK Biopharmaceuticals (326030 KS)

Closure of Register of Shareholders or Designation of Record Date

Conclusion of Single Sales Contract or Supply Contract

Material Business Matters Related to Investment Decisions

Conclusion of Single Sales Contract or Supply Contract

[Revised] Conclusion of Single Sales Contract or Supply Contract

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)